New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2013
10:01 EDTICADiCAD initiated with a Buy at Craig-Hallum
Target $9.
News For ICAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2015
08:08 EDTICADiCAD announces positive results from trial evaluating the Xoft System
iCAD announced first-year data from the company's ExBRT trial evaluating the Xoft System for the treatment of early stage breast cancer will be presented at the American Brachytherapy Society Annual Meeting in Orlando, FL. "Early results from the ExBRT study suggest that this short course of full dose radiation in a single treatment delivers good to excellent cosmetic results in 94% of cases and very few low-grade adverse events in select patients with early-stage breast cancer," said Dr. Nisar Syed, investigator of the multi-center ExBRT study. "I am very encouraged by the results as IORT may also improve patient quality of life by greatly reducing the number of treatments patients receive when compared to EBRT."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use